LIXT
Lixte Biotechnology Holdings Inc
3.70$
-1.3%
vs. previous close
Closing price · As of: Sep 3, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +10.9% | -27.5% | +215.7% | +217.0% | -38.4% | +95.7% | -2.6% | +9.2% | -22.5% | -73.4% | +1,011.6% | |
| – | +10.9% | -27.5% | +215.7% | +216.8% | -38.4% | +95.7% | -2.6% | +9.2% | -23.9% | -75.4% | +398.4% | |
| – | -43.1% | +690.8% | +553.1% | +227.2% | -39.2% | +95.1% | -4.8% | +11.0% | -21.5% | -75.3% | +391.5% | |
| – | -49.9% | +54.5% | +553.1% | +227.2% | -39.2% | +95.1% | -4.8% | +11.0% | -21.5% | -75.3% | +391.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +4.5% | -23.5% | +70.6% | -43.5% | +12.8% | -9.0% | +39.9% | +30.3% | -20.5% | +1.4% | +456.8% | |
| – | +4.5% | -23.5% | +70.6% | -43.5% | +12.8% | -9.0% | +39.9% | +30.3% | -20.5% | +1.4% | +318.8% | |
| – | +254.9% | -51.8% | +3.3% | +245.8% | +12.8% | – | – | +30.3% | -20.5% | – | – | |
| – | +29.8% | +0.3% | +95.5% | -37.4% | -26.5% | +32.6% | +18.7% | +1.7% | -31.8% | -46.9% | +524,480.0% | |
| – | +17.5% | -31.2% | +363.3% | +314.6% | -41.0% | +105.9% | -4.4% | +7.8% | -22.7% | -79.3% | +1,068.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +5.4% | +2.3% | +16.6% | +5.3% | +14.0% | +0.9% | +19.5% | -88.3% | +1,111.0% | +17.4% | +2,052.4% |
Data as of: September 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.